Smokers Clinical Trial
Official title:
Efficacy of Cognitive Behaviour Therapy Associated to Nicotine Replacement in Tobacco Cessation: a Randomised Open Label Clinical Trial
Background: Pharmacological strategies to improve smoking cessation have been largely
studied. The efficacy of cognitive behavior therapy associated to nicotine replacement in
tobacco cessation has not yet been demonstrated.
Objective: Evaluate if cognitive behavior therapy during six weeks associated to nicotine
replacement for twelve weeks is able to contribute to tobacco cessation at the end of 52
weeks.
Methods: Multicentre, open-label, and pragmatic randomized controlled trial will include 334
patients. Analysis will follow intention-to-treat principle.
Patients older than 18 years old and who had smoked at least 5 cigarettes in the past year
before randomization will be included.
All of them will receive nicotine replacement therapy with patches and gum. They will be
randomized 1:1 ratio to attend or not cognitive behavior therapy once a week for the first
six weeks of the treatment. Every two weeks all of the patients will be evaluated by a
physician in order to access any adverse effects from the nicotine replacement.
All patients will have carbon monoxide levels accessed at baseline and after 6 weeks.
Telephonic interview will be done at 16, 28, and 52 weeks to access the rates of tobacco
cessation, relapses episodes and abstinence maintenance.
n/a
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06123598 -
Effects of Mental Practice and Therapeutic Exercise in Mild Smokers
|
N/A | |
Active, not recruiting |
NCT06108323 -
Immediate Effects of Mental Practice and Therapeutic Exercise in Mild Smokers
|
N/A | |
Completed |
NCT01213706 -
Effect of Whole Body Periodic Acceleration on Airway Endothelial Function
|
N/A | |
Completed |
NCT00781599 -
Improving Medication Compliance and Smoking Cessation Treatment Outcomes for African American Smokers
|
N/A | |
Completed |
NCT02354677 -
Repair, Remodeling and Regeneration of the Bronchial Epithelium of COPD Patients
|
N/A | |
Completed |
NCT00918073 -
Evaluation of Cardiovascular Effects of Smoking Cessation in HIV Patients
|
N/A | |
Not yet recruiting |
NCT03299634 -
Oral Mucosal Lesions Among Smokers in an Egyptian Population Study.
|
N/A | |
Completed |
NCT03299595 -
Oral Mucosal Lesions Among Smokers in an Egyptian Population.
|
||
Completed |
NCT00483015 -
Differences in the Presentation Outcome and Response to Treatment Between Never- Smokers and Smokers With NSCLC
|
N/A | |
Completed |
NCT01182129 -
4 mg Nicotine Polacrilex Gum and Swedish Portion Snus
|
Phase 1/Phase 2 | |
Terminated |
NCT01345383 -
Impact of Current Smoking in the Tolerance of Bronchoscopy
|
N/A | |
Completed |
NCT01362101 -
Effect of Behavioral Training on Physiological Responses to Smoking Cues, Affect and Cortisol
|
Phase 4 | |
Completed |
NCT00341640 -
Metabolism of Nicotine and Cotinine in Pregnant African-American Women
|
Phase 1 | |
Completed |
NCT03086707 -
Prefatory Study to Explore Changes in Nasal Mucociliary Clearance and to Standardize Nasal Scraping Procedure
|
N/A | |
Completed |
NCT01566968 -
Novel Endpoints in Cough Challenge Testing
|
N/A | |
Active, not recruiting |
NCT05758272 -
Evaluation of a Workplace Smoking Cessation Program in Hong Kong (Phase VI)
|
N/A | |
Completed |
NCT03608293 -
Smoker Extracellular Vesicles Influence on Human Bronchial Epithelial Cells
|
N/A | |
Not yet recruiting |
NCT04252781 -
Incident Chronic Obstructive pulmoNary dIsease Cohort Study (ICONIC)
|
N/A | |
Completed |
NCT00369616 -
Efficacy and Safety of Nicotine-Qbeta Vaccine in Smokers
|
Phase 2 | |
Completed |
NCT04099225 -
Multiple Breath Washout (MBW) Using Sulfur Hexafluoride Reference Values and Influence of Anthropometric Parameters
|